Simultaneous integrated boost to intraprostatic lesions using different energy levels of intensity-modulated radiotherapy and volumetric-arc therapy

British Journal of Radiology

Volumn 87, Issue 1034, 2014, Pages

  Onal, C ^a   Sonmez, S ^a   Erbay, G ^a   Guler, O C ^a   Arslan, G ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL TARGET VOLUME; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; DIFFUSION COEFFICIENT; DOSIMETRY; ENERGY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; INTERMETHOD COMPARISON; IONIZATION CHAMBER; LINEAR ACCELERATOR; MALE; MONTE CARLO METHOD; MULTILEAF COLLIMATOR; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHANTOM; PROSTATE; PROSTATE CANCER; RADIATION DOSE; RADIOLOGIST; RADIOTHERAPY PLANNING SYSTEM; TARGET ORGAN; TREATMENT PLANNING; VOLUMETRIC ARC THERAPY; COMPARATIVE STUDY; COMPUTER ASSISTED RADIOTHERAPY; EVALUATION STUDY; METHODOLOGY; PROSTATE TUMOR;

ALGORITHMS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84893416582     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr.20130617     Document Type: Article

References (34)

1. Zietman AL, DeSilvio ML, Slater JD, Rossi CJ Jr, Miller DW, Adams JA, et al. Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial. J Am Med Assoc 2005; 294: 1233-39. doi: 10.1001/jama.294.10.1233 (Pubitemid 41352111)
2. Morgan PB, Hanlon AL, Horwitz EM, Buyyounouski MK, Uzzo RG, Pollack A. Radiation dose and late failures in prostate cancer. Int J Radiat Oncol Biol Phys 2007; 67: 1074-81. doi: 10.1016/j.ijrobp.2006.10.023
3. Cellini N, Morganti AG, Mattiucci GC, Valentini V, Leone M, Luzi S, et al. Analysis of intraprostatic failures in patients treated with hormonal therapy and radiotherapy: implications for conformal therapy planning. Int J Radiat Oncol Biol Phys 2002; 53: 595-99. (Pubitemid 34626498)
4. Ost P, Speleers B, De Meerleer G, De Neve W, Fonteyne V, Villeirs G, et al. Volumetric arc therapy and intensity-modulated radiotherapy for primary prostate radiotherapy with simultaneous integrated boost to intraprostatic lesion with 6 and 18 MV: a planning comparison study. Int J Radiat Oncol Biol Phys 2011; 79: 920-26.
5. Fonteyne V, Villeirs G, Speleers B, De Neve W, De Wagter C, Lumen N, et al. Intensity-modulated radiotherapy as primary therapy for prostate cancer: report on acute toxicity after dose escalation with simultaneous integrated boost to intraprostatic lesion. Int J Radiat Oncol Biol Phys 2008; 72: 799-807.
6. 18F-choline PET-CT detected simultaneous integrated boost. Radiother Oncol 2009; 93: 213-19.
7. Ishii K, Ogino R, Okada W, Nakahara R, Kawamorita R, Nakajima T. A dosimetric comparison of RapidArc and IMRT with hypofractionated simultaneous integrated boost to the prostate for treatment of prostate cancer. Br J Radiol 2013; 86: 20130199 doi: 10.1259/bjr.20130199
8. Pasler M, Georg D, Wirtz H, Lutterbach J. Effect of photon-beam energy on VMAT and IMRT treatment plan quality and dosimetric accuracy for advanced prostate cancer. Strahlenther Onkol 2011; 187: 792-98. doi: 10.1007/s00066-011- 1150-0
9. Wolff D, Stieler F, Welzel G, Lorenz F, Abo-Madyan Y, Mai S, et al. Volumetric modulated arc therapy (VMAT) vs. serial tomotherapy, step-and-shoot IMRT and 3D-conformal RT for treatment of prostate cancer. Radiother Oncol 2009; 93: 226-33. doi: 10.1016/j.radonc.2009.08.011
10. Palma D, Vollans E, James K, Nakano S, Moiseenko V, Shaffer R, et al. Volumetric modulated arc therapy for delivery of prostate radiotherapy: comparison with intensity-modulated radiotherapy and three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 2008; 72: 996-1001.
11. Hussein M, Aldridge S, Guerrero Urbano T, Nisbet A. The effect of 6 and 15 MV on intensity-modulated radiation therapy prostate cancer treatment: plan evaluation, tumour control probability and normal tissue complication probability analysis, and the theoretical risk of secondary induced malignancies. Br J Radiol 2012; 85: 423-32.
12. Schneider U, Lomax A, Pemler P, Besserer J, Ross D, Lombriser N, et al. The impact of IMRT and proton radiotherapy on secondary cancer incidence. Strahlenther Onkol 2006; 182: 647-52. doi: 10.1007/s00066-006-1534-8 (Pubitemid 44657651)
13. Villeirs GM, De Meerleer GO, De Visschere PJ, Fonteyne VH, Verbaeys AC, Oosterlinck W. Combined magnetic resonance imaging and spectroscopy in the assessment of high grade prostate carcinoma in patients with elevated PSA: a single-institution experience of 356 patients. Eur J Radiol 2011; 77: 340-45. doi: 10.1016/j.ejrad.2009.08.007
14. De Meerleer G, Villeirs G, Bral S, Paelinck L, De Gersem W, Dekuyper P, et al. The magnetic resonance detected intraprostatic lesion in prostate cancer: planning and delivery of intensity-modulated radiotherapy. Radiother Oncol 2005; 75: 325-33. doi: 10.1016/j.radonc.2005.04.014 (Pubitemid 41007979)
15. Jackson AS, Reinsberg SA, Sohaib SA, Charles-Edwards EM, Jhavar S, Christmas TJ, et al. Dynamic contrast-enhanced MRI for prostate cancer localization. Br J Radiol 2009; 82: 148-56. doi: 10.1259/bjr/89518905
16. Dogan N, Mihaylov I, Wu Y, Keall PJ, Siebers JV, Hagan MP. Monte Carlo dose verification of prostate patients treated with simultaneous integrated boost intensity modulated radiation therapy. Radiat Oncol 2009; 4: 18. doi: 10.1186/1748-717X-4-18
17. Yang J, Li J, Chen L, Price R, McNeeley S, Qin L, et al. Dosimetric verification of IMRT treatment planning using Monte Carlo simulations for prostate cancer. Phys Med Biol 2005; 50: 869-78. (Pubitemid 40477309)
18. Cruz M, Tsuda K, Narumi Y, Kuroiwa Y, Nose T, Kojima Y, et al. Characterization of low-intensity lesions in the peripheral zone of prostate on pre-biopsy endorectal coil MR imaging. Eur Radiol 2002; 12: 357-65. doi: 10.1007/s003300101044 (Pubitemid 36940072)
19. Onal C, Topkan E, Efe E, Yavuz M, Arslan G, Yavuz A. The effect of concurrent androgen deprivation and 3D conformal radiotherapy on prostate volume and clinical organ doses during treatment for prostate cancer. Br J Radiol 2009; 82: 1019-26. doi: 10.1259/bjr/65939531
20. Chen M, Hricak H, Kalbhen CL, Kurhanewicz J, Vigneron DB, Weiss JM, et al. Hormonal ablation of prostatic cancer: effects on prostate morphology, tumor detection, and staging by endorectal coil MR imaging. AJR Am J Roentgenol 1996; 166: 1157-63. doi: 10.2214/ajr.166.5.8615261 (Pubitemid 26122964)
21. Housri N, Ning H, Ondos J, Choyke P, Camphausen K, Citrin D, et al. Parameters favorable to intraprostatic radiation dose escalation in men with localized prostate cancer. Int J Radiat Oncol Biol Phys 2011; 80: 614-20. doi: 10.1016/j.ijrobp.2010.06.050
22. Sannazzari GL, Ragona R, Ruo Redda MG, Giglioli FR, Isolato G, Guarneri A. CT-MRI image fusion for delineation of volumes in three-dimensional conformal radiation therapy in the treatment of localized prostate cancer. Br J Radiol 2002; 75: 603-7. (Pubitemid 34830612)
23. Tsai CL, Wu JK, Chao HL, Tsai YC, Cheng JC. Treatment and dosimetric advantages between VMAT, IMRT, and helical tomotherapy in prostate cancer. Med Dosim 2011; 36: 264-71. doi: 10.1016/j.meddos.2010.05.001
24. Onal C, Topkan E, Efe E, Yavuz M, Sonmez S, Yavuz A. Comparison of rectal volume definition techniques and their influence on rectal toxicity in patients with prostate cancer treated with 3D conformal radiotherapy: a dose-volume analysis. Radiat Oncol 2009; 4: 14. doi: 10.1186/1748-717X-4-14
25. Otto K. Volumetric modulated arc therapy: IMRT in a single gantry arc. Med Phys 2008; 35: 310-17.
26. Lawton CA, Michalski J, El-Naqa I, Buyyounouski MK, Lee WR, Menard C, et al. RTOG GU Radiation oncology specialists reach consensus on pelvic lymph node volumes for high-risk prostate cancer. Int J Radiat Oncol Biol Phys 2009; 74: 383-87. doi: 10.1016/j.ijrobp.2008.08.002
27. Kutcher GJ, Burman C. Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method. Int J Radiat Oncol Biol Phys 1989; 16: 1623-30. (Pubitemid 19154353)
28. Burman C, Kutcher GJ, Emami B, Goitein M. Fitting of normal tissue tolerance data to an analytic function. Int J Radiat Oncol Biol Phys 1991; 21: 123-35.
29. Geier M, Astner ST, Duma MN, Jacob V, Nieder C, Putzhammer J, et al. Dose-escalated simultaneous integrated-boost treatment of prostate cancer patients via helical tomotherapy. Strahlenther Onkol 2012; 188: 410-16. doi: 10.1007/s00066-012-0081-8
30. Futterer JJ, Heijmink SW, Scheenen TW, Veltman J, Huisman HJ, Vos P, et al. Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging. Radiology 2006; 241: 449-58. doi: 10.1148/radiol.2412051866 (Pubitemid 44632891)
31. Speight JL, Roach M 3rd. Advances in the treatment of localized prostate cancer: the role of anatomic and functional imaging in men managed with radiotherapy. J Clin Oncol 2007; 25: 987-95. doi: 10.1200/JCO.2006.10.3218 (Pubitemid 350002865)
32. Villeirs GM, L Verstraete K, De Neve WJ, De Meerleer GO. Magnetic resonance imaging anatomy of the prostate and periprostatic area: a guide for radiotherapists. Radiother Oncol 2005; 76: 99-106. doi: 10.1016/j.radonc.2005. 06.015 (Pubitemid 41096522)
33. Lafond C, Gassa F, Odin C, Drean G, Even J, De Crevoisier R, et al. Comparison between two treatment planning systems for volumetric modulated arc therapy optimization for prostate cancer. Phys Med 2014; 30: 2-9. doi: 10.1016/j.ejmp.2012.10.003
34. Wiezorek T, Voigt A, Metzger N, Georg D, Schwedas M, Salz H, et al. Experimental determination of peripheral doses for different IMRT techniques delivered by a Siemens linear accelerator. Strahlenther Onkol 2008; 184: 73-9. doi: 10.1007/s00066-008-1743-4 (Pubitemid 351231654)